Compare CHRD & TXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CHRD | TXG |
|---|---|---|
| Founded | 2007 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Laboratory Analytical Instruments |
| Sector | Energy | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.4B | 9.3B |
| IPO Year | 2010 | 2019 |
| Metric | CHRD | TXG |
|---|---|---|
| Price | $145.79 | $53.41 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 18 | 17 |
| Target Price | ★ $182.75 | $68.14 |
| AVG Volume (30 Days) | 769.9K | ★ 3.0M |
| Earning Date | 11-04-2026 | 11-05-2026 |
| Dividend Yield | ★ 3.54% | N/A |
| EPS Growth | N/A | ★ 76.97 |
| EPS | ★ 14.47 | N/A |
| Revenue | N/A | ★ $245,893,000.00 |
| Revenue This Year | $53.11 | N/A |
| Revenue Next Year | N/A | $11.72 |
| P/E Ratio | $10.15 | ★ N/A |
| Revenue Growth | N/A | ★ 68.06 |
| 52 Week Low | $87.35 | $15.18 |
| 52 Week High | $159.96 | $102.81 |
| Indicator | CHRD | TXG |
|---|---|---|
| Relative Strength Index (RSI) | 50.91 | 36.17 |
| Support Level | $130.54 | $18.13 |
| Resistance Level | $152.12 | $63.82 |
| Average True Range (ATR) | 5.62 | 5.65 |
| MACD | 0.19 | -1.21 |
| Stochastic Oscillator | 56.81 | 4.85 |
Chord Energy Corp is an independent exploration and production (E&P) company engaged in the acquisition, exploration, development and production of crude oil, NGL and natural gas prominently in the Williston Basin, with limited non-operated interests in the Marcellus Shale. It operates in one reportable business segment, which is the E&P of crude oil, NGL and natural gas. The company derives revenue from the sale of crude oil, NGL and natural gas production.
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives operates from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).